Montréal, Quebec, Canada Related Funds
Funds with similar focus
| Fund Name | Location |
| ASR | - |
| BIRD Energy | Israel, Tel Aviv, Tel Aviv |
| Blank Slate Ventures | Chattanooga, Tennessee, United States |
| DGS | - |
| easyJet PLC | Genoa, Italy, Liguria |
| Echo Broadband | Germany, Nordrhein-Westfalen, Siegburg |
| Global Philanthropic | - |
| Guangdong Billionhome Fund Management | China, Guangdong, Guangzhou |
| Hangzhou Dekuan Technology | China, Hangzhou, Zhejiang |
| Huamin | China, Foochow, Fujian |
| Huayuan Shuju | China, Jingan, Shanghai |
| Inner Loop Capital | Baltimore, Maryland, United States |
| Involved Investors | - |
| Iporanga Ventures | Brazil, São Paulo, Sao Paulo |
| LAUNCHub Ventures | Bulgaria, Grad Sofiya, Sofia |
| Ningbo GQY | - |
| Sansan | Chiyoda, Japan |
| Sino-Rock Investment Management | China, Hong Kong, Hong Kong Island |
| Techstars Los Angeles Accelerator | California, Los Angeles, United States |
| Yeahmobi | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
nplex biosciences | $42M | 17 Sep 2024 | Montreal, Quebec, Canada | ||
Radiant Biotherapeutics | $35M | 11 Sep 2024 | Toronto, Ontario, Canada | ||
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Ability biologics | $12M | 06 Dec 2023 | Quebec, Quebec, Canada | ||
Reverb Therapeutics | 15 Nov 2023 | Vancouver, British Columbia, Canada | |||
Tentarix Biotherapeutics | $35M | 06 Sep 2023 | La Jolla, California, United States | ||
Evommune | $50M | 26 Apr 2023 | California, United States | ||
Radiant Biotherapeutics | $8M | 25 Apr 2023 | Toronto, Ontario, Canada | ||
Congruence Therapeutics | $15M | 06 Mar 2023 | Montréal, Quebec, Canada |
– Deep Genomics announced the closing of a $180m Series C financing round.
– The round was led by SoftBank Vision Fund 2 and includes participation from new investors, Canadian Pension Plan Investment Board, Fidelity Management & Research Company, Alexandria Venture Investments, and existing investors Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures.
– Deep Genomics uses AI and machine learning to program and prioritize transformational RNA therapeutics for genetic diseases.
– The company has leveraged its strategic geographical advantage by combining its teams in Toronto, the birthplace of deep learning and the fastest growing technology hub in North America, with the Boston-Cambridge biotechnology hub, by hiring Jeffrey Brown, PhD, as VP of Preclinical Research, Ferdinand Massari, MD, as Chief Medical Officer, and Amanda Kay, PhD, as Chief Business Officer.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
nplex biosciences | $42M | 17 Sep 2024 | Montreal, Quebec, Canada | ||
Radiant Biotherapeutics | $35M | 11 Sep 2024 | Toronto, Ontario, Canada | ||
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Ability biologics | $12M | 06 Dec 2023 | Quebec, Quebec, Canada | ||
Reverb Therapeutics | 15 Nov 2023 | Vancouver, British Columbia, Canada | |||
Tentarix Biotherapeutics | $35M | 06 Sep 2023 | La Jolla, California, United States | ||
Evommune | $50M | 26 Apr 2023 | California, United States | ||
Radiant Biotherapeutics | $8M | 25 Apr 2023 | Toronto, Ontario, Canada | ||
Congruence Therapeutics | $15M | 06 Mar 2023 | Montréal, Quebec, Canada |
